Figure 7
From: The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers
CD133 mRNA expression in ovarian (OVCAR-8 and IGROV-1) and endometrial (Ishikawa) cancer cell lines after treatment with Trichostatin A (TSA), 5-aza-2`-deoxycytidine (DAC), or both. * Representative results of real-time PCR analysis of CD133 expression in three cell lines with or without 5-aza-2`-deoxycytidine (DAC) and Trichostatin A (TSA). * Results are representative of three independent experiments.